MYRIAD GENETICS, INC. Number of Operating Segments
MYRIAD GENETICS, INC. (MYGN) reported Number of Operating Segments of 1 segment for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-24.
Financial Statements › Notes › Segment Reporting
us-gaap:NumberOfOperatingSegments · last filed 2026-02-24
- MYRIAD GENETICS, INC. number of operating segments for the quarter ending 2025-03-31 was 1.00 segment, a 0.00% change year-over-year.
- MYRIAD GENETICS, INC. number of operating segments for the quarter ending 2024-03-31 was 1.00 segment, a 0.00% change year-over-year.
- MYRIAD GENETICS, INC. number of operating segments for the quarter ending 2023-03-31 was 1.00 segment.
- MYRIAD GENETICS, INC. number of operating segments for fiscal 2025 was 1.00 segment, a 0.00% change from fiscal 2024.
- MYRIAD GENETICS, INC. number of operating segments for fiscal 2024 was 1.00 segment.
| Period end | Number of Operating Segments 3 month | Number of Operating Segments 6 month | Number of Operating Segments 9 month | Number of Operating Segments 12 month |
|---|---|---|---|---|
| 2025-12-31 | 1.00 segment 10-K · filed 2026-02-24 | |||
| 2025-09-30 | 1.00 segment 10-Q · filed 2025-11-04 | |||
| 2025-06-30 | 1.00 segment 10-Q · filed 2025-08-06 | |||
| 2025-03-31 | 1.00 segment 10-Q · filed 2025-05-07 | |||
| 2024-12-31 | 1.00 segment 10-K · filed 2025-02-28 | |||
| 2024-09-30 | 1.00 segment 10-Q · filed 2024-11-08 | |||
| 2024-06-30 | 1.00 segment 10-Q · filed 2024-08-07 | |||
| 2024-03-31 | 1.00 segment 10-Q · filed 2024-05-08 | |||
| 2023-09-30 | 1.00 segment 10-Q · filed 2023-11-07 | |||
| 2023-06-30 | 1.00 segment 10-Q · filed 2023-08-04 | |||
| 2023-03-31 | 1.00 segment 10-Q · filed 2023-05-04 | |||
| 2022-09-30 | 1.00 segment 10-Q · filed 2022-11-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |